Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesGRAIL, LLC

GRAIL, LLC

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
121.44 USD 2.31 ( 1.94%)
Last update at 2026-11-06T21:08:00Z
VOLUME
755913
Market Cap
3389.72M

Momentum Score

…

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
117.00
Low
129.70
High
52 Week Price Range
38.89
Low
118.84
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
119.13
Dividend Yield
-
Revenue TTM
165.26M
Revenue Per Share
4.11
Gross Profit TTM
82.15M
Debt / Equity
0.04
ROE
-16.12%
Net Debt
-151.72M
ROCE
-18.79%
Diluted EPS TTM
-9.69

Insight News

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -534.50M -2162.36M -1507.64M -5441.39M -1265.25M
Net income -408.35M -2027.01M -1465.68M -5399.10M -1247.78M
Selling general administrative 159.10M 213.86M 200.27M 174.11M 180.53M
Selling and marketing expenses 116.69M 153.96M 162.29M 122.33M 53.53M
Gross profit -62.57M -78.02M -95.61M -116.45M -100.00M
Reconciled depreciation 156.34M 158.06M 158.70M 154.76M -
Ebit -534.16M -768.22M -796.92M -742.46M -1265.25M
Ebitda -377.82M -610.17M -638.22M -587.70M -1206.80M
Depreciation and amortization 156.34M 158.06M 158.70M 154.76M 58.45M
Operating income -534.16M -2189.16M -1515.38M -5442.89M -1265.34M
Other operating expenses 681.34M 2314.75M 1608.49M 5498.44M 1279.95M
Tax provision -126.15M -135.36M -223.98M -42.29M -
Interest income 28.65M 26.73M 7.95M 1.74M -
Net interest income 28.65M 26.73M 7.95M 1.74M -
Income tax expense -126.15M -135.36M -41.95M -42.29M -17.48M
Total revenue 147.17M 125.59M 93.11M 55.55M 14.61M
Total operating expenses 471.59M 2111.14M 1419.77M 5326.44M 1165.34M
Cost of revenue 209.75M 203.62M 188.72M 172.00M 114.61M
Total other income expense net -0.34M 26.80M 7.75M 1.50M 0.09M
Net income from continuing ops -408.35M -2027.01M -1283.65M -5399.10M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2922.01M 2983.31M 4556.93M 5602.10M 9737.92M
Intangible assets 1850.56M 2016.89M 2687.22M 2935.56M 3073.89M
Other current assets 15.11M 13.12M 14.73M 15.67M 14.70M
Total liab 344.15M 479.90M 910.74M 955.94M 307.40M
Total stockholder equity 2577.86M 2503.41M 3646.19M 4646.16M 9430.52M
Other current liab 65.87M 57.22M 129.13M 104.12M 66.43M
Common stock 0.04M 0.03M 11421.45M 10955.91M 10341.75M
Capital stock 0.04M 0.03M - - -
Retained earnings -10211.68M -9803.33M -7776.32M -6310.64M -911.54M
Good will - 0.00M 888.94M 1497.40M 6197.83M
Other assets - - -643.11M - -
Cash 249.73M 214.23M 97.29M 241.60M 221.16M
Total current liabilities 79.67M 76.92M 163.61M 134.94M 97.89M
Current deferred revenue - 1.60M - - -
Net debt -151.72M -146.09M -12.88M -145.59M -110.60M
Short term debt 11.71M 13.26M 14.81M 13.34M 13.81M
Short long term debt total 98.01M 68.14M 84.41M 96.01M 110.56M
Other stockholder equity 12786.85M 12305.25M - - 0.00M
Total current assets 953.85M 819.86M 156.06M 295.63M 242.73M
Short term investments 654.70M 549.24M 0.00M - -
Net receivables 18.30M 24.64M 22.35M 18.61M 6.88M
Inventory 16.02M 18.63M 21.70M 19.75M -
Accounts payable 2.08M 4.84M 19.67M 17.48M 17.65M
Accumulated other comprehensive income 2.65M 1.45M 1.07M 0.89M 0.31M
Non currrent assets other 6.75M 11.12M 7.98M 6.14M 7.10M
Non current assets total 1968.17M 2163.45M 4400.86M 5306.47M 9495.19M
Capital lease obligations 54.86M 68.14M 84.41M 96.01M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -84.14M -551.01M -12.89M -22.86M -
Total cashflows from investing activities -85.05M -551.01M -12.89M -22.86M 344.81M
Total cash from financing activities 423.32M 1244.30M 463.77M 604.82M 394.74M
Net income -408.35M -2027.01M -1465.68M -5399.10M -1247.78M
Change in cash 39.12M 116.07M -144.62M 20.13M -143.19M
Begin period cash flow 217.58M 101.51M 246.13M 225.99M 143.19M
End period cash flow 256.70M 217.58M 101.51M 246.13M 802.04M
Total cash from operating activities -299.01M -577.16M -595.80M -561.31M -688.13M
Issuance of capital stock 418.80M 0.00M 0.00M - -
Depreciation 156.34M 158.06M 158.70M 154.76M 58.45M
Other cashflows from investing activities -85.05M - - - 414.74M
Change to inventory 2.62M 3.07M -1.94M -14.08M -5.67M
Change to account receivables 1.69M -3.37M -1.38M -8.68M -6.88M
Sale purchase of stock - - -0.23M -4.18M -0.17M
Other cashflows from financing activities 423.32M 1244.30M 463.77M 604.82M 388.93M
Capital expenditures 0.91M 5.21M 12.89M 22.86M 69.93M
Change in working capital 12.41M -24.28M 7.72M -14.46M 20.29M
Stock based compensation 58.28M 86.08M 97.23M 75.73M 681.91M
Other non cash items 96.94M 1364.24M 644.38M 4660.82M -201.00M
Free cash flow -299.01M -582.36M -608.69M -584.17M -758.06M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
GRAL
GRAIL, LLC		 2.31
1.94%		 121.44 - - 20.51 1.33 15.75
TMO
Thermo Fisher Scientific Inc		 17.82
2.63%		 694.76 34.71 23.87 4.62 4.43 5.29
DHR
Danaher Corporation		 3.91
1.73%		 230.25 29.09 28.01 5.67 3.20 6.00
WUXIF
WuXi AppTec Co. Ltd		 -
-%		 25.45 22.29 17.95 1.53 5.98 8.39
WUXAY
WuXi AppTec Co. Ltd		 -0.31
1.23%		 24.85 23.28 18.73 1.51 6.24 8.39

Profile*

GRAIL, LLC

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

1525 O?Brien Drive, Menlo Park, CA, United States, 94025

833 694 2553

https://grail.com

910

Name Title Year Born
Mr. Robert P. Ragusa CEO & Director 1960
Dr. Joshua J. Ofman M.D., M.S.H.S President & Director 1965
Mr. Aaron Freidin Chief Financial Officer 1979
Mr. Paul Ciccolella Senior Vice President of Global Development & Operations NA
Sir Harpal S. Kumar M.A., M.B.A., MEng Chief Scientific Officer & President International NA
Mr. Abram Barth J.D., M.P.H. Chief Legal Officer & Corporate Secretary NA
Alexis Tosti VP of Strategy & Corporate Development NA
Ms. Alison Highlander Senior VP of Human Resources & Head of People Team NA
Dr. Satnam Alag Ph.D. Senior VP of Software Engineering & Chief Security Officer NA
Mr. Andrew John Partridge Chief Commercial Officer 1969

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…